DR. SCOTT A ARMSTRONG, MD, PHD
Medical Practice at Longwood Ave, Boston, MA

License number
Massachusetts 157119
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address 2
300 Longwood Ave, Boston, MA 02115
22 Deer Run, Wayland, MA 01778
Phone
(617) 632-3951
(508) 358-2992

Personal information

See more information about SCOTT A ARMSTRONG at radaris.com
Name
Address
Phone
Scott Armstrong
4 Flaxfield Rd, Dudley, MA 01571
Scott Armstrong
50 Sheehan Rd, Lynn, MA 01904
Scott Armstrong
380 School St, Whitman, MA 02382
Scott Armstrong, age 47
3 Williams Ct, Woburn, MA 01801
Scott F Armstrong, age 47
51 Grant St, Somerville, MA 02145

Organization information

See more information about SCOTT A ARMSTRONG at bizstanding.com

Scott Armstrong MD,PHD

44 Binney St, Boston, MA 02115

Industry:
Pediatric Oncologist, Pediatrician, Internist
Phone:
(617) 632-3951 (Phone)
Scott Allen Armstrong

Professional information

Scott Armstrong Photo 1

Assistant Professor Of Pediatrics At Dana-Farber Cancer Institute

Position:
Assistant Professor of Pediatrics at Dana-Farber Cancer Institute
Location:
Greater Boston Area
Industry:
Research
Work:
Dana-Farber Cancer Institute - Assistant Professor of Pediatrics


Scott Allen Armstrong Photo 2

Scott Allen Armstrong, Boston MA

Specialties:
Pediatrics, Pediatric Hematology-Oncology, Hematology, Hematology & Oncology
Work:
Dana-Farber Cancer Institute
44 Binney St, Boston, MA 02115 Children's Hospital
300 Longwood Ave, Boston, MA 02115 Danielsen Institute
450 Brookline Ave, Boston, MA 02215 Dana Farber Cancer
40 Buttrick Rd, Londonderry, NH 03053 Dana Farber Cancer Institute
20 Prospect St, Milford, MA 01757
Education:
The University of Texas Southwestern (1996)


Scott Armstrong Photo 3

Teacher At Plymouth Public Schools

Position:
Teacher at Plymouth Public Schools
Location:
Greater Boston Area
Industry:
Education Management
Work:
Plymouth Public Schools - Teacher


Scott A Armstrong Photo 4

Dr. Scott A Armstrong, Boston MA - MD (Doctor of Medicine)

Specialties:
Pediatric Hematology & Oncology
Address:
300 Longwood Ave, Boston 02115
(617) 632-3951 (Phone), (617) 730-4860 (Fax)
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6000 (Phone)
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6117 (Phone), (617) 738-7066 (Fax)
Certifications:
Pediatric Oncology & Pediatric Hematology, 2010, Pediatrics, 2001
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
300 Longwood Ave, Boston 02115
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
Brigham and Women's Hospital
75 Francis St, Boston 02115
Massachusetts General Hospital
55 Fruit St, Boston 02114
North Shore Medical Center - Salem Hospital
81 Highland Ave, Salem 01970
Education:
Medical School
University Of Texas Southwestern Medical Center At Dallas
Graduated: 1996
Boston Combined Program
Dana Farber Cancer Institute


Scott Armstrong Photo 5

Math Teacher At Andover High School

Position:
MAth teacher at Andover high school
Location:
Greater Boston Area
Industry:
Education Management
Work:
Andover high school - MAth teacher


Scott A Armstrong Photo 6

Scott A Armstrong, Boston MA

Specialties:
Pediatrician
Address:
44 Binney St, Boston, MA 02115
300 Longwood Ave, Boston, MA 02115
1275 York Ave, New York, NY 10065


Scott Armstrong Photo 7

Novel Signature Self Renewal Gene Expression Programs

US Patent:
2009032, Dec 31, 2009
Filed:
Mar 26, 2007
Appl. No.:
12/294195
Inventors:
Scott A. Armstrong - Wayland MA, US
Andrei V. Krivtsov - Malden MA, US
International Classification:
A61K 39/395, C12Q 1/68, A61K 31/7088, A61K 31/7105, C12N 5/06, G01N 33/574
US Classification:
4241781, 435 6, 514 44 A, 435325, 435 723
Abstract:
The present invention relates to compounds and methods which are useful in molecular investigations of target genes, as well as their encoded RNAs and protein, belonging to signature self renewal programs in leukemia and/or cancer stem cells. Data herein shows that leukemia stem cells can be generated from committed progenitors without widespread reprogramming of gene expression, and wherein a leukemia self-renewal associated signature is activated in the process.


Scott Armstrong Photo 8

Mll Translocations Specify A Distinct Gene Expression Profile, Distinguishing A Unique Leukemia

US Patent:
2006005, Mar 16, 2006
Filed:
Oct 20, 2005
Appl. No.:
11/256381
Inventors:
Todd Golub - Newton MA, US
Scott Armstrong - Wayland MA, US
Stanley Korsmeyer - Weston MA, US
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
The present invention relates to the diagnosis of mixed lineage leukemia (MLL), acute lymphoblastic leukemia (ALL), and acute myelogenous leukemia (AML) according to the gene expression profile of a sample from an individual, as well as to methods of therapy and screening that utilize the genes identified herein as targets.


Scott Armstrong Photo 9

Mll Translocations Specify A Distinct Gene Expression Profile, Distinguishing A Unique Leukemia

US Patent:
2006002, Feb 2, 2006
Filed:
Sep 22, 2005
Appl. No.:
11/233905
Inventors:
Todd Golub - Newton MA, US
Scott Armstrong - Wayland MA, US
Stanley Korsmeyer - Weston MA, US
International Classification:
C12Q 1/68, G01N 33/574
US Classification:
435006000, 435007230
Abstract:
The present invention relates to the diagnosis of mixed lineage leukemia (MLL), acute lymphoblastic leukemia (ALL), and acute myelogenous leukemia (AML) according to the gene expression profile of a sample from an individual, as well as to methods of therapy and screening that utilize the genes identified herein as targets.


Scott Armstrong Photo 10

Mll Translocations Specify A Distinct Gene Expression Profile, Distinguishing A Unique Leukemia

US Patent:
7011947, Mar 14, 2006
Filed:
Jul 17, 2002
Appl. No.:
10/198064
Inventors:
Todd R. Golub - Newton MA, US
Scott A. Armstrong - Wayland MA, US
Stanley J. Korsmeyer - Weston MA, US
Assignee:
Whitehead Institute for Biomedical Research - Cambridge MA
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
C12Q 1/68, C12Q 1/02, G01N 33/53
US Classification:
435 6, 435 71, 435 29
Abstract:
The present invention relates to the diagnosis of mixed lineage leukemia (MLL), acute lymphoblastic leukemia (ALL), and acute myelogenous leukemia (AML) according to the gene expression profile of a sample from an individual, as well as to methods of therapy and screening that utilize the genes identified herein as targets.